nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CA9—hematologic cancer	0.276	1	CbGaD
Indapamide—CA7—Imatinib—hematologic cancer	0.0469	0.11	CbGbCtD
Indapamide—CA7—Nilotinib—hematologic cancer	0.0426	0.0997	CbGbCtD
Indapamide—CA12—Imatinib—hematologic cancer	0.0403	0.0942	CbGbCtD
Indapamide—CA9—Imatinib—hematologic cancer	0.0403	0.0942	CbGbCtD
Indapamide—CA9—Nilotinib—hematologic cancer	0.0366	0.0856	CbGbCtD
Indapamide—CA12—Nilotinib—hematologic cancer	0.0366	0.0856	CbGbCtD
Indapamide—CA2—Imatinib—hematologic cancer	0.0326	0.0761	CbGbCtD
Indapamide—CA4—Nilotinib—hematologic cancer	0.0322	0.0753	CbGbCtD
Indapamide—CA2—Nilotinib—hematologic cancer	0.0296	0.0692	CbGbCtD
Indapamide—CYP3A4—Bexarotene—hematologic cancer	0.00745	0.0174	CbGbCtD
Indapamide—CYP3A4—Lomustine—hematologic cancer	0.00692	0.0162	CbGbCtD
Indapamide—CYP3A4—Busulfan—hematologic cancer	0.00692	0.0162	CbGbCtD
Indapamide—CYP3A4—Thiotepa—hematologic cancer	0.00617	0.0144	CbGbCtD
Indapamide—CYP3A4—Methoxsalen—hematologic cancer	0.0048	0.0112	CbGbCtD
Indapamide—CYP3A4—Bortezomib—hematologic cancer	0.00456	0.0107	CbGbCtD
Indapamide—CYP3A4—Daunorubicin—hematologic cancer	0.00436	0.0102	CbGbCtD
Indapamide—KCNE1—hematopoietic system—hematologic cancer	0.00432	0.123	CbGeAlD
Indapamide—CYP3A4—Cytarabine—hematologic cancer	0.00385	0.00901	CbGbCtD
Indapamide—CYP3A4—Teniposide—hematologic cancer	0.00379	0.00887	CbGbCtD
Indapamide—CYP3A4—Ifosfamide—hematologic cancer	0.0035	0.00819	CbGbCtD
Indapamide—CYP3A4—Imatinib—hematologic cancer	0.00334	0.00782	CbGbCtD
Indapamide—KCNE1—gonad—hematologic cancer	0.00328	0.0935	CbGeAlD
Indapamide—CYP3A4—Ruxolitinib—hematologic cancer	0.00315	0.00736	CbGbCtD
Indapamide—CYP3A4—Nilotinib—hematologic cancer	0.00304	0.00711	CbGbCtD
Indapamide—CYP3A4—Vinorelbine—hematologic cancer	0.00301	0.00705	CbGbCtD
Indapamide—KCNE1—blood—hematologic cancer	0.00286	0.0815	CbGeAlD
Indapamide—CYP3A4—Triamcinolone—hematologic cancer	0.00276	0.00645	CbGbCtD
Indapamide—CYP3A4—Dasatinib—hematologic cancer	0.00269	0.00628	CbGbCtD
Indapamide—CYP3A4—Mitoxantrone—hematologic cancer	0.00265	0.0062	CbGbCtD
Indapamide—KCNE1—lung—hematologic cancer	0.00251	0.0715	CbGeAlD
Indapamide—KCNE1—testis—hematologic cancer	0.00236	0.0674	CbGeAlD
Indapamide—CYP3A4—Betamethasone—hematologic cancer	0.00236	0.00553	CbGbCtD
Indapamide—CYP3A4—Prednisolone—hematologic cancer	0.00233	0.00546	CbGbCtD
Indapamide—CYP3A4—Prednisone—hematologic cancer	0.0022	0.00515	CbGbCtD
Indapamide—CYP3A4—Irinotecan—hematologic cancer	0.00209	0.00488	CbGbCtD
Indapamide—CYP3A4—Vinblastine—hematologic cancer	0.00186	0.00434	CbGbCtD
Indapamide—CYP3A4—Vincristine—hematologic cancer	0.00183	0.00427	CbGbCtD
Indapamide—CYP3A4—Etoposide—hematologic cancer	0.00167	0.00391	CbGbCtD
Indapamide—CYP3A4—Dexamethasone—hematologic cancer	0.00138	0.00322	CbGbCtD
Indapamide—KCNQ1—blood—hematologic cancer	0.00131	0.0374	CbGeAlD
Indapamide—KCNQ1—bone marrow—hematologic cancer	0.00127	0.0362	CbGeAlD
Indapamide—CA5B—hematopoietic system—hematologic cancer	0.00127	0.0361	CbGeAlD
Indapamide—SLC12A3—lung—hematologic cancer	0.00124	0.0353	CbGeAlD
Indapamide—KCNQ1—lung—hematologic cancer	0.00115	0.0328	CbGeAlD
Indapamide—CYP3A4—Doxorubicin—hematologic cancer	0.00114	0.00267	CbGbCtD
Indapamide—KCNQ1—testis—hematologic cancer	0.00109	0.031	CbGeAlD
Indapamide—CA9—testis—hematologic cancer	0.00105	0.0299	CbGeAlD
Indapamide—CA5B—gonad—hematologic cancer	0.000964	0.0275	CbGeAlD
Indapamide—CA5B—blood—hematologic cancer	0.00084	0.0239	CbGeAlD
Indapamide—CA12—lung—hematologic cancer	0.000821	0.0234	CbGeAlD
Indapamide—KCNQ1—lymph node—hematologic cancer	0.000787	0.0224	CbGeAlD
Indapamide—CA5B—lung—hematologic cancer	0.000736	0.021	CbGeAlD
Indapamide—CA2—hematopoietic system—hematologic cancer	0.000726	0.0207	CbGeAlD
Indapamide—CA5B—testis—hematologic cancer	0.000695	0.0198	CbGeAlD
Indapamide—Furosemide—CA9—hematologic cancer	0.000689	0.259	CrCbGaD
Indapamide—Metolazone—CA9—hematologic cancer	0.000662	0.249	CrCbGaD
Indapamide—CA4—blood—hematologic cancer	0.00058	0.0165	CbGeAlD
Indapamide—CA4—bone marrow—hematologic cancer	0.000561	0.016	CbGeAlD
Indapamide—Bumetanide—CA9—hematologic cancer	0.000522	0.196	CrCbGaD
Indapamide—Chlorthalidone—CA9—hematologic cancer	0.000512	0.192	CrCbGaD
Indapamide—CA4—lung—hematologic cancer	0.000508	0.0145	CbGeAlD
Indapamide—CA5B—lymph node—hematologic cancer	0.000504	0.0144	CbGeAlD
Indapamide—CA2—blood—hematologic cancer	0.000481	0.0137	CbGeAlD
Indapamide—CA4—testis—hematologic cancer	0.00048	0.0137	CbGeAlD
Indapamide—CYP3A4—hematopoietic system—hematologic cancer	0.000468	0.0133	CbGeAlD
Indapamide—CA2—bone marrow—hematologic cancer	0.000465	0.0133	CbGeAlD
Indapamide—CA2—lung—hematologic cancer	0.000421	0.012	CbGeAlD
Indapamide—CA2—testis—hematologic cancer	0.000398	0.0113	CbGeAlD
Indapamide—CA4—lymph node—hematologic cancer	0.000348	0.00991	CbGeAlD
Indapamide—CYP3A4—blood—hematologic cancer	0.00031	0.00884	CbGeAlD
Indapamide—CA2—lymph node—hematologic cancer	0.000288	0.00822	CbGeAlD
Indapamide—Furosemide—ALB—hematologic cancer	0.000173	0.0651	CrCbGaD
Indapamide—Oxcarbazepine—ALB—hematologic cancer	0.000104	0.0392	CrCbGaD
Indapamide—CA2—Metabolism—CRABP1—hematologic cancer	2.09e-05	0.000358	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC22A1—hematologic cancer	2.09e-05	0.000358	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NQO1—hematologic cancer	2.08e-05	0.000356	CbGpPWpGaD
Indapamide—CA7—Metabolism—NQO1—hematologic cancer	2.08e-05	0.000356	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CD44—hematologic cancer	2.08e-05	0.000356	CbGpPWpGaD
Indapamide—CA7—Metabolism—CD44—hematologic cancer	2.08e-05	0.000356	CbGpPWpGaD
Indapamide—CA9—Metabolism—ACP5—hematologic cancer	2.07e-05	0.000355	CbGpPWpGaD
Indapamide—CA4—Metabolism—NUP98—hematologic cancer	2.06e-05	0.000352	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOR2—hematologic cancer	2.04e-05	0.00035	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALOX5—hematologic cancer	2.04e-05	0.000349	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—JUN—hematologic cancer	2.01e-05	0.000344	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.01e-05	0.000343	CbGpPWpGaD
Indapamide—CA4—Metabolism—ADCY7—hematologic cancer	2e-05	0.000342	CbGpPWpGaD
Indapamide—CA4—Metabolism—NCOA3—hematologic cancer	2e-05	0.000342	CbGpPWpGaD
Indapamide—CA4—Metabolism—NUP214—hematologic cancer	1.98e-05	0.000339	CbGpPWpGaD
Indapamide—CA2—Metabolism—NUP98—hematologic cancer	1.97e-05	0.000338	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYCS—hematologic cancer	1.97e-05	0.000337	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYCS—hematologic cancer	1.97e-05	0.000337	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HSP90AA1—hematologic cancer	1.95e-05	0.000335	CbGpPWpGaD
Indapamide—CA7—Metabolism—HSP90AA1—hematologic cancer	1.95e-05	0.000335	CbGpPWpGaD
Indapamide—CA9—Metabolism—IDH1—hematologic cancer	1.95e-05	0.000333	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN1A—hematologic cancer	1.95e-05	0.000333	CbGpPWpGaD
Indapamide—CA4—Metabolism—MTR—hematologic cancer	1.94e-05	0.000333	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCG2—hematologic cancer	1.94e-05	0.000333	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCC3—hematologic cancer	1.93e-05	0.00033	CbGpPWpGaD
Indapamide—CA12—Metabolism—NQO1—hematologic cancer	1.93e-05	0.00033	CbGpPWpGaD
Indapamide—CA12—Metabolism—CD44—hematologic cancer	1.93e-05	0.00033	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTO1—hematologic cancer	1.93e-05	0.00033	CbGpPWpGaD
Indapamide—CA9—Metabolism—TXN—hematologic cancer	1.93e-05	0.00033	CbGpPWpGaD
Indapamide—CA2—Metabolism—ADCY7—hematologic cancer	1.91e-05	0.000328	CbGpPWpGaD
Indapamide—CA2—Metabolism—NCOA3—hematologic cancer	1.91e-05	0.000328	CbGpPWpGaD
Indapamide—CA4—Metabolism—ENO2—hematologic cancer	1.91e-05	0.000326	CbGpPWpGaD
Indapamide—CA2—Metabolism—NUP214—hematologic cancer	1.9e-05	0.000325	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MAPK8—hematologic cancer	1.9e-05	0.000325	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	1.9e-05	0.000325	CbGpPWpGaD
Indapamide—CA9—Metabolism—SPHK1—hematologic cancer	1.88e-05	0.000323	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.88e-05	0.000321	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	1.87e-05	0.00032	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTR—hematologic cancer	1.86e-05	0.000319	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCG2—hematologic cancer	1.86e-05	0.000319	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTP1—hematologic cancer	1.86e-05	0.000318	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—EP300—hematologic cancer	1.85e-05	0.000317	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTT1—hematologic cancer	1.85e-05	0.000316	CbGpPWpGaD
Indapamide—CA2—Metabolism—ENO2—hematologic cancer	1.83e-05	0.000313	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYCS—hematologic cancer	1.82e-05	0.000312	CbGpPWpGaD
Indapamide—CA12—Metabolism—HSP90AA1—hematologic cancer	1.81e-05	0.00031	CbGpPWpGaD
Indapamide—CA9—Metabolism—UGT1A1—hematologic cancer	1.81e-05	0.00031	CbGpPWpGaD
Indapamide—CA4—Metabolism—SDC1—hematologic cancer	1.81e-05	0.000309	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	1.78e-05	0.000305	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTT1—hematologic cancer	1.77e-05	0.000303	CbGpPWpGaD
Indapamide—CA9—Metabolism—CRABP1—hematologic cancer	1.76e-05	0.000302	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC22A1—hematologic cancer	1.76e-05	0.000302	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ABCB1—hematologic cancer	1.76e-05	0.000301	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.76e-05	0.000301	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—hematologic cancer	1.75e-05	0.0003	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—STAT3—hematologic cancer	1.74e-05	0.000297	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTP1—hematologic cancer	1.73e-05	0.000297	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTP1—hematologic cancer	1.73e-05	0.000297	CbGpPWpGaD
Indapamide—CA2—Metabolism—SDC1—hematologic cancer	1.73e-05	0.000296	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALOX5—hematologic cancer	1.72e-05	0.000294	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NCOR1—hematologic cancer	1.71e-05	0.000292	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTM1—hematologic cancer	1.71e-05	0.000292	CbGpPWpGaD
Indapamide—CA9—Metabolism—NUP98—hematologic cancer	1.66e-05	0.000285	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MAPK3—hematologic cancer	1.66e-05	0.000284	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ABCB1—hematologic cancer	1.64e-05	0.000281	CbGpPWpGaD
Indapamide—CA7—Metabolism—ABCB1—hematologic cancer	1.64e-05	0.000281	CbGpPWpGaD
Indapamide—CA9—Metabolism—ADCY7—hematologic cancer	1.61e-05	0.000276	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOA3—hematologic cancer	1.61e-05	0.000276	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTP1—hematologic cancer	1.61e-05	0.000275	CbGpPWpGaD
Indapamide—CA9—Metabolism—NUP214—hematologic cancer	1.6e-05	0.000274	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTM1—hematologic cancer	1.59e-05	0.000273	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTM1—hematologic cancer	1.59e-05	0.000273	CbGpPWpGaD
Indapamide—CA7—Metabolism—NCOR1—hematologic cancer	1.59e-05	0.000273	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NCOR1—hematologic cancer	1.59e-05	0.000273	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.57e-05	0.000269	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTR—hematologic cancer	1.57e-05	0.000269	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCG2—hematologic cancer	1.57e-05	0.000269	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.55e-05	0.000265	CbGpPWpGaD
Indapamide—CA9—Metabolism—ENO2—hematologic cancer	1.54e-05	0.000264	CbGpPWpGaD
Indapamide—CA4—Metabolism—CD44—hematologic cancer	1.54e-05	0.000263	CbGpPWpGaD
Indapamide—CA4—Metabolism—NQO1—hematologic cancer	1.54e-05	0.000263	CbGpPWpGaD
Indapamide—CA12—Metabolism—ABCB1—hematologic cancer	1.52e-05	0.00026	CbGpPWpGaD
Indapamide—Erythema multiforme—Doxorubicin—hematologic cancer	1.51e-05	7.51e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—MTHFR—hematologic cancer	1.51e-05	0.000258	CbGpPWpGaD
Indapamide—Rash—Cisplatin—hematologic cancer	1.5e-05	7.49e-05	CcSEcCtD
Indapamide—Dermatitis—Cisplatin—hematologic cancer	1.5e-05	7.49e-05	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—hematologic cancer	1.5e-05	7.48e-05	CcSEcCtD
Indapamide—Erythema—Epirubicin—hematologic cancer	1.5e-05	7.48e-05	CcSEcCtD
Indapamide—Diarrhoea—Etoposide—hematologic cancer	1.5e-05	7.45e-05	CcSEcCtD
Indapamide—Anorexia—Prednisone—hematologic cancer	1.49e-05	7.44e-05	CcSEcCtD
Indapamide—CA9—Metabolism—GSTT1—hematologic cancer	1.49e-05	0.000256	CbGpPWpGaD
Indapamide—Ill-defined disorder—Methotrexate—hematologic cancer	1.49e-05	7.41e-05	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—hematologic cancer	1.49e-05	7.41e-05	CcSEcCtD
Indapamide—Anaemia—Methotrexate—hematologic cancer	1.48e-05	7.38e-05	CcSEcCtD
Indapamide—Feeling abnormal—Betamethasone—hematologic cancer	1.48e-05	7.38e-05	CcSEcCtD
Indapamide—Feeling abnormal—Dexamethasone—hematologic cancer	1.48e-05	7.38e-05	CcSEcCtD
Indapamide—Flushing—Doxorubicin—hematologic cancer	1.48e-05	7.38e-05	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—hematologic cancer	1.48e-05	7.38e-05	CcSEcCtD
Indapamide—Flatulence—Epirubicin—hematologic cancer	1.48e-05	7.37e-05	CcSEcCtD
Indapamide—CA12—Metabolism—GSTM1—hematologic cancer	1.48e-05	0.000253	CbGpPWpGaD
Indapamide—CA12—Metabolism—NCOR1—hematologic cancer	1.48e-05	0.000253	CbGpPWpGaD
Indapamide—Tension—Epirubicin—hematologic cancer	1.47e-05	7.34e-05	CcSEcCtD
Indapamide—CA2—Metabolism—CD44—hematologic cancer	1.47e-05	0.000252	CbGpPWpGaD
Indapamide—CA2—Metabolism—NQO1—hematologic cancer	1.47e-05	0.000252	CbGpPWpGaD
Indapamide—Gastrointestinal pain—Betamethasone—hematologic cancer	1.47e-05	7.33e-05	CcSEcCtD
Indapamide—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.47e-05	7.33e-05	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—hematologic cancer	1.47e-05	7.32e-05	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.47e-05	0.000252	CbGpPWpGaD
Indapamide—Hypersensitivity—Triamcinolone—hematologic cancer	1.46e-05	7.28e-05	CcSEcCtD
Indapamide—CA9—Metabolism—SDC1—hematologic cancer	1.46e-05	0.00025	CbGpPWpGaD
Indapamide—Nervousness—Epirubicin—hematologic cancer	1.46e-05	7.26e-05	CcSEcCtD
Indapamide—CA4—Metabolism—CYCS—hematologic cancer	1.45e-05	0.000249	CbGpPWpGaD
Indapamide—Back pain—Epirubicin—hematologic cancer	1.45e-05	7.23e-05	CcSEcCtD
Indapamide—Malaise—Methotrexate—hematologic cancer	1.45e-05	7.21e-05	CcSEcCtD
Indapamide—Dizziness—Etoposide—hematologic cancer	1.45e-05	7.2e-05	CcSEcCtD
Indapamide—CA4—Metabolism—HSP90AA1—hematologic cancer	1.44e-05	0.000247	CbGpPWpGaD
Indapamide—Muscle spasms—Epirubicin—hematologic cancer	1.44e-05	7.19e-05	CcSEcCtD
Indapamide—Vertigo—Methotrexate—hematologic cancer	1.44e-05	7.18e-05	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—hematologic cancer	1.44e-05	7.15e-05	CcSEcCtD
Indapamide—Urticaria—Dexamethasone—hematologic cancer	1.43e-05	7.12e-05	CcSEcCtD
Indapamide—Urticaria—Betamethasone—hematologic cancer	1.43e-05	7.12e-05	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.43e-05	7.11e-05	CcSEcCtD
Indapamide—Dizziness—Prednisolone—hematologic cancer	1.43e-05	7.1e-05	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—hematologic cancer	1.43e-05	7.1e-05	CcSEcCtD
Indapamide—Asthenia—Triamcinolone—hematologic cancer	1.42e-05	7.08e-05	CcSEcCtD
Indapamide—Body temperature increased—Betamethasone—hematologic cancer	1.42e-05	7.08e-05	CcSEcCtD
Indapamide—Abdominal pain—Betamethasone—hematologic cancer	1.42e-05	7.08e-05	CcSEcCtD
Indapamide—Abdominal pain—Dexamethasone—hematologic cancer	1.42e-05	7.08e-05	CcSEcCtD
Indapamide—Body temperature increased—Dexamethasone—hematologic cancer	1.42e-05	7.08e-05	CcSEcCtD
Indapamide—Nausea—Cisplatin—hematologic cancer	1.42e-05	7.06e-05	CcSEcCtD
Indapamide—Insomnia—Prednisone—hematologic cancer	1.42e-05	7.06e-05	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—hematologic cancer	1.41e-05	7.05e-05	CcSEcCtD
Indapamide—CA7—Metabolism—MTHFR—hematologic cancer	1.41e-05	0.000241	CbGpPWpGaD
Indapamide—CA5B—Metabolism—MTHFR—hematologic cancer	1.41e-05	0.000241	CbGpPWpGaD
Indapamide—Paraesthesia—Prednisone—hematologic cancer	1.41e-05	7.01e-05	CcSEcCtD
Indapamide—Pruritus—Triamcinolone—hematologic cancer	1.4e-05	6.99e-05	CcSEcCtD
Indapamide—Cough—Methotrexate—hematologic cancer	1.4e-05	6.97e-05	CcSEcCtD
Indapamide—Ill-defined disorder—Epirubicin—hematologic cancer	1.39e-05	6.94e-05	CcSEcCtD
Indapamide—CA2—Metabolism—CYCS—hematologic cancer	1.39e-05	0.000238	CbGpPWpGaD
Indapamide—Vomiting—Etoposide—hematologic cancer	1.39e-05	6.92e-05	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—hematologic cancer	1.39e-05	6.92e-05	CcSEcCtD
Indapamide—Erythema—Doxorubicin—hematologic cancer	1.39e-05	6.92e-05	CcSEcCtD
Indapamide—Anaemia—Epirubicin—hematologic cancer	1.39e-05	6.91e-05	CcSEcCtD
Indapamide—CA2—Metabolism—HSP90AA1—hematologic cancer	1.38e-05	0.000237	CbGpPWpGaD
Indapamide—Agitation—Epirubicin—hematologic cancer	1.38e-05	6.87e-05	CcSEcCtD
Indapamide—Dyspepsia—Prednisone—hematologic cancer	1.38e-05	6.87e-05	CcSEcCtD
Indapamide—Rash—Etoposide—hematologic cancer	1.38e-05	6.86e-05	CcSEcCtD
Indapamide—Dermatitis—Etoposide—hematologic cancer	1.38e-05	6.86e-05	CcSEcCtD
Indapamide—Headache—Etoposide—hematologic cancer	1.37e-05	6.82e-05	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—hematologic cancer	1.37e-05	6.82e-05	CcSEcCtD
Indapamide—Chest pain—Methotrexate—hematologic cancer	1.37e-05	6.8e-05	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—hematologic cancer	1.37e-05	6.8e-05	CcSEcCtD
Indapamide—Myalgia—Methotrexate—hematologic cancer	1.37e-05	6.8e-05	CcSEcCtD
Indapamide—Tension—Doxorubicin—hematologic cancer	1.36e-05	6.79e-05	CcSEcCtD
Indapamide—Decreased appetite—Prednisone—hematologic cancer	1.36e-05	6.78e-05	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—hematologic cancer	1.36e-05	6.78e-05	CcSEcCtD
Indapamide—Rash—Prednisolone—hematologic cancer	1.36e-05	6.77e-05	CcSEcCtD
Indapamide—Dermatitis—Prednisolone—hematologic cancer	1.36e-05	6.76e-05	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.36e-05	6.76e-05	CcSEcCtD
Indapamide—Malaise—Epirubicin—hematologic cancer	1.35e-05	6.74e-05	CcSEcCtD
Indapamide—Fatigue—Prednisone—hematologic cancer	1.35e-05	6.73e-05	CcSEcCtD
Indapamide—Headache—Prednisolone—hematologic cancer	1.35e-05	6.73e-05	CcSEcCtD
Indapamide—Discomfort—Methotrexate—hematologic cancer	1.35e-05	6.72e-05	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—hematologic cancer	1.35e-05	6.72e-05	CcSEcCtD
Indapamide—Vertigo—Epirubicin—hematologic cancer	1.35e-05	6.72e-05	CcSEcCtD
Indapamide—Syncope—Epirubicin—hematologic cancer	1.35e-05	6.71e-05	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—hematologic cancer	1.34e-05	6.69e-05	CcSEcCtD
Indapamide—Back pain—Doxorubicin—hematologic cancer	1.34e-05	6.69e-05	CcSEcCtD
Indapamide—Constipation—Prednisone—hematologic cancer	1.34e-05	6.67e-05	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—hematologic cancer	1.34e-05	6.65e-05	CcSEcCtD
Indapamide—Palpitations—Epirubicin—hematologic cancer	1.33e-05	6.61e-05	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—TP53—hematologic cancer	1.32e-05	0.000227	CbGpPWpGaD
Indapamide—Loss of consciousness—Epirubicin—hematologic cancer	1.32e-05	6.57e-05	CcSEcCtD
Indapamide—Dizziness—Triamcinolone—hematologic cancer	1.31e-05	6.53e-05	CcSEcCtD
Indapamide—Cough—Epirubicin—hematologic cancer	1.31e-05	6.52e-05	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—hematologic cancer	1.31e-05	6.52e-05	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—hematologic cancer	1.31e-05	6.52e-05	CcSEcCtD
Indapamide—CA12—Metabolism—MTHFR—hematologic cancer	1.3e-05	0.000223	CbGpPWpGaD
Indapamide—Infection—Methotrexate—hematologic cancer	1.3e-05	6.48e-05	CcSEcCtD
Indapamide—Nausea—Etoposide—hematologic cancer	1.3e-05	6.47e-05	CcSEcCtD
Indapamide—Feeling abnormal—Prednisone—hematologic cancer	1.29e-05	6.43e-05	CcSEcCtD
Indapamide—Asthenia—Betamethasone—hematologic cancer	1.29e-05	6.43e-05	CcSEcCtD
Indapamide—Asthenia—Dexamethasone—hematologic cancer	1.29e-05	6.43e-05	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—hematologic cancer	1.29e-05	6.42e-05	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—hematologic cancer	1.28e-05	6.39e-05	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—hematologic cancer	1.28e-05	6.39e-05	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—hematologic cancer	1.28e-05	6.38e-05	CcSEcCtD
Indapamide—Gastrointestinal pain—Prednisone—hematologic cancer	1.28e-05	6.38e-05	CcSEcCtD
Indapamide—CA4—Metabolism—GSTP1—hematologic cancer	1.28e-05	0.000219	CbGpPWpGaD
Indapamide—Nausea—Prednisolone—hematologic cancer	1.28e-05	6.38e-05	CcSEcCtD
Indapamide—Myalgia—Epirubicin—hematologic cancer	1.28e-05	6.37e-05	CcSEcCtD
Indapamide—Chest pain—Epirubicin—hematologic cancer	1.28e-05	6.37e-05	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—hematologic cancer	1.28e-05	6.37e-05	CcSEcCtD
Indapamide—Agitation—Doxorubicin—hematologic cancer	1.28e-05	6.36e-05	CcSEcCtD
Indapamide—Anxiety—Epirubicin—hematologic cancer	1.27e-05	6.34e-05	CcSEcCtD
Indapamide—Pruritus—Betamethasone—hematologic cancer	1.27e-05	6.34e-05	CcSEcCtD
Indapamide—Pruritus—Dexamethasone—hematologic cancer	1.27e-05	6.34e-05	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—hematologic cancer	1.27e-05	6.33e-05	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.27e-05	6.32e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—PIK3CG—hematologic cancer	1.27e-05	0.000217	CbGpPWpGaD
Indapamide—Hyperhidrosis—Methotrexate—hematologic cancer	1.27e-05	6.3e-05	CcSEcCtD
Indapamide—Discomfort—Epirubicin—hematologic cancer	1.26e-05	6.29e-05	CcSEcCtD
Indapamide—Vomiting—Triamcinolone—hematologic cancer	1.26e-05	6.28e-05	CcSEcCtD
Indapamide—Malaise—Doxorubicin—hematologic cancer	1.25e-05	6.24e-05	CcSEcCtD
Indapamide—Rash—Triamcinolone—hematologic cancer	1.25e-05	6.23e-05	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—hematologic cancer	1.25e-05	6.23e-05	CcSEcCtD
Indapamide—Dermatitis—Triamcinolone—hematologic cancer	1.25e-05	6.22e-05	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—hematologic cancer	1.25e-05	6.22e-05	CcSEcCtD
Indapamide—Anorexia—Methotrexate—hematologic cancer	1.25e-05	6.22e-05	CcSEcCtD
Indapamide—Syncope—Doxorubicin—hematologic cancer	1.25e-05	6.2e-05	CcSEcCtD
Indapamide—Urticaria—Prednisone—hematologic cancer	1.24e-05	6.2e-05	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—hematologic cancer	1.24e-05	6.19e-05	CcSEcCtD
Indapamide—Headache—Triamcinolone—hematologic cancer	1.24e-05	6.19e-05	CcSEcCtD
Indapamide—CA9—Metabolism—NQO1—hematologic cancer	1.24e-05	0.000212	CbGpPWpGaD
Indapamide—CA9—Metabolism—CD44—hematologic cancer	1.24e-05	0.000212	CbGpPWpGaD
Indapamide—Abdominal pain—Prednisone—hematologic cancer	1.24e-05	6.17e-05	CcSEcCtD
Indapamide—Body temperature increased—Prednisone—hematologic cancer	1.24e-05	6.17e-05	CcSEcCtD
Indapamide—Diarrhoea—Betamethasone—hematologic cancer	1.23e-05	6.13e-05	CcSEcCtD
Indapamide—Diarrhoea—Dexamethasone—hematologic cancer	1.23e-05	6.13e-05	CcSEcCtD
Indapamide—CA2—Metabolism—GSTP1—hematologic cancer	1.23e-05	0.00021	CbGpPWpGaD
Indapamide—Palpitations—Doxorubicin—hematologic cancer	1.23e-05	6.11e-05	CcSEcCtD
Indapamide—Oedema—Epirubicin—hematologic cancer	1.23e-05	6.1e-05	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—hematologic cancer	1.23e-05	6.1e-05	CcSEcCtD
Indapamide—Hypotension—Methotrexate—hematologic cancer	1.22e-05	6.09e-05	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—hematologic cancer	1.22e-05	6.08e-05	CcSEcCtD
Indapamide—Infection—Epirubicin—hematologic cancer	1.22e-05	6.06e-05	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—IL6—hematologic cancer	1.21e-05	0.000208	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCB1—hematologic cancer	1.21e-05	0.000208	CbGpPWpGaD
Indapamide—Cough—Doxorubicin—hematologic cancer	1.21e-05	6.04e-05	CcSEcCtD
Indapamide—Shock—Epirubicin—hematologic cancer	1.21e-05	6e-05	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—hematologic cancer	1.2e-05	5.98e-05	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—hematologic cancer	1.2e-05	5.97e-05	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—hematologic cancer	1.2e-05	5.96e-05	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.19e-05	5.94e-05	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—hematologic cancer	1.19e-05	5.93e-05	CcSEcCtD
Indapamide—Dizziness—Dexamethasone—hematologic cancer	1.19e-05	5.92e-05	CcSEcCtD
Indapamide—Dizziness—Betamethasone—hematologic cancer	1.19e-05	5.92e-05	CcSEcCtD
Indapamide—Hyperhidrosis—Epirubicin—hematologic cancer	1.18e-05	5.9e-05	CcSEcCtD
Indapamide—Insomnia—Methotrexate—hematologic cancer	1.18e-05	5.9e-05	CcSEcCtD
Indapamide—CA5B—Metabolism—PIK3CG—hematologic cancer	1.18e-05	0.000203	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CG—hematologic cancer	1.18e-05	0.000203	CbGpPWpGaD
Indapamide—Myalgia—Doxorubicin—hematologic cancer	1.18e-05	5.89e-05	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—hematologic cancer	1.18e-05	5.89e-05	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—hematologic cancer	1.18e-05	5.89e-05	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—hematologic cancer	1.18e-05	5.87e-05	CcSEcCtD
Indapamide—Nausea—Triamcinolone—hematologic cancer	1.18e-05	5.87e-05	CcSEcCtD
Indapamide—CA4—Metabolism—NCOR1—hematologic cancer	1.18e-05	0.000201	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTM1—hematologic cancer	1.18e-05	0.000201	CbGpPWpGaD
Indapamide—Paraesthesia—Methotrexate—hematologic cancer	1.18e-05	5.86e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—CREBBP—hematologic cancer	1.17e-05	0.000201	CbGpPWpGaD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.17e-05	5.85e-05	CcSEcCtD
Indapamide—CA9—Metabolism—CYCS—hematologic cancer	1.17e-05	0.000201	CbGpPWpGaD
Indapamide—Discomfort—Doxorubicin—hematologic cancer	1.17e-05	5.82e-05	CcSEcCtD
Indapamide—Anorexia—Epirubicin—hematologic cancer	1.17e-05	5.82e-05	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—hematologic cancer	1.17e-05	5.81e-05	CcSEcCtD
Indapamide—CA9—Metabolism—HSP90AA1—hematologic cancer	1.17e-05	0.0002	CbGpPWpGaD
Indapamide—Somnolence—Methotrexate—hematologic cancer	1.16e-05	5.8e-05	CcSEcCtD
Indapamide—CA2—Metabolism—ABCB1—hematologic cancer	1.16e-05	0.000199	CbGpPWpGaD
Indapamide—Dry mouth—Doxorubicin—hematologic cancer	1.16e-05	5.76e-05	CcSEcCtD
Indapamide—Hypersensitivity—Prednisone—hematologic cancer	1.15e-05	5.75e-05	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—hematologic cancer	1.15e-05	5.74e-05	CcSEcCtD
Indapamide—Hypotension—Epirubicin—hematologic cancer	1.14e-05	5.7e-05	CcSEcCtD
Indapamide—Vomiting—Dexamethasone—hematologic cancer	1.14e-05	5.7e-05	CcSEcCtD
Indapamide—Vomiting—Betamethasone—hematologic cancer	1.14e-05	5.7e-05	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—hematologic cancer	1.14e-05	5.67e-05	CcSEcCtD
Indapamide—Rash—Dexamethasone—hematologic cancer	1.13e-05	5.65e-05	CcSEcCtD
Indapamide—Rash—Betamethasone—hematologic cancer	1.13e-05	5.65e-05	CcSEcCtD
Indapamide—Oedema—Doxorubicin—hematologic cancer	1.13e-05	5.65e-05	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—hematologic cancer	1.13e-05	5.65e-05	CcSEcCtD
Indapamide—Dermatitis—Betamethasone—hematologic cancer	1.13e-05	5.64e-05	CcSEcCtD
Indapamide—Dermatitis—Dexamethasone—hematologic cancer	1.13e-05	5.64e-05	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.13e-05	5.63e-05	CcSEcCtD
Indapamide—Fatigue—Methotrexate—hematologic cancer	1.13e-05	5.62e-05	CcSEcCtD
Indapamide—CA2—Metabolism—NCOR1—hematologic cancer	1.13e-05	0.000193	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTM1—hematologic cancer	1.13e-05	0.000193	CbGpPWpGaD
Indapamide—Headache—Betamethasone—hematologic cancer	1.13e-05	5.61e-05	CcSEcCtD
Indapamide—Headache—Dexamethasone—hematologic cancer	1.13e-05	5.61e-05	CcSEcCtD
Indapamide—Infection—Doxorubicin—hematologic cancer	1.13e-05	5.61e-05	CcSEcCtD
Indapamide—Asthenia—Prednisone—hematologic cancer	1.12e-05	5.6e-05	CcSEcCtD
Indapamide—Pain—Methotrexate—hematologic cancer	1.12e-05	5.58e-05	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.12e-05	5.56e-05	CcSEcCtD
Indapamide—Shock—Doxorubicin—hematologic cancer	1.12e-05	5.56e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—PIK3CD—hematologic cancer	1.11e-05	0.000191	CbGpPWpGaD
Indapamide—Nervous system disorder—Doxorubicin—hematologic cancer	1.11e-05	5.54e-05	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—hematologic cancer	1.11e-05	5.53e-05	CcSEcCtD
Indapamide—Pruritus—Prednisone—hematologic cancer	1.11e-05	5.52e-05	CcSEcCtD
Indapamide—Insomnia—Epirubicin—hematologic cancer	1.11e-05	5.52e-05	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—hematologic cancer	1.11e-05	5.51e-05	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—hematologic cancer	1.1e-05	5.48e-05	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—hematologic cancer	1.1e-05	5.48e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—ALB—hematologic cancer	1.1e-05	0.000188	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CREBBP—hematologic cancer	1.1e-05	0.000188	CbGpPWpGaD
Indapamide—CA7—Metabolism—CREBBP—hematologic cancer	1.1e-05	0.000188	CbGpPWpGaD
Indapamide—Hyperhidrosis—Doxorubicin—hematologic cancer	1.1e-05	5.46e-05	CcSEcCtD
Indapamide—CA12—Metabolism—PIK3CG—hematologic cancer	1.1e-05	0.000188	CbGpPWpGaD
Indapamide—Dyspnoea—Epirubicin—hematologic cancer	1.09e-05	5.44e-05	CcSEcCtD
Indapamide—Somnolence—Epirubicin—hematologic cancer	1.09e-05	5.43e-05	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—hematologic cancer	1.08e-05	5.38e-05	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—hematologic cancer	1.08e-05	5.37e-05	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—hematologic cancer	1.08e-05	5.37e-05	CcSEcCtD
Indapamide—Diarrhoea—Prednisone—hematologic cancer	1.07e-05	5.34e-05	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—hematologic cancer	1.07e-05	5.33e-05	CcSEcCtD
Indapamide—Nausea—Betamethasone—hematologic cancer	1.07e-05	5.32e-05	CcSEcCtD
Indapamide—Nausea—Dexamethasone—hematologic cancer	1.07e-05	5.32e-05	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—hematologic cancer	1.07e-05	5.3e-05	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—hematologic cancer	1.06e-05	5.28e-05	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.06e-05	5.27e-05	CcSEcCtD
Indapamide—Fatigue—Epirubicin—hematologic cancer	1.06e-05	5.26e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—PIK3R1—hematologic cancer	1.05e-05	0.00018	CbGpPWpGaD
Indapamide—Constipation—Epirubicin—hematologic cancer	1.05e-05	5.22e-05	CcSEcCtD
Indapamide—Pain—Epirubicin—hematologic cancer	1.05e-05	5.22e-05	CcSEcCtD
Indapamide—Urticaria—Methotrexate—hematologic cancer	1.04e-05	5.18e-05	CcSEcCtD
Indapamide—CA4—Metabolism—MTHFR—hematologic cancer	1.04e-05	0.000178	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CD—hematologic cancer	1.04e-05	0.000178	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CD—hematologic cancer	1.04e-05	0.000178	CbGpPWpGaD
Indapamide—Dizziness—Prednisone—hematologic cancer	1.04e-05	5.16e-05	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—hematologic cancer	1.04e-05	5.15e-05	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—hematologic cancer	1.04e-05	5.15e-05	CcSEcCtD
Indapamide—CA9—Metabolism—GSTP1—hematologic cancer	1.03e-05	0.000177	CbGpPWpGaD
Indapamide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.03e-05	5.14e-05	CcSEcCtD
Indapamide—CA5B—Metabolism—ALB—hematologic cancer	1.03e-05	0.000176	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALB—hematologic cancer	1.03e-05	0.000176	CbGpPWpGaD
Indapamide—Insomnia—Doxorubicin—hematologic cancer	1.03e-05	5.11e-05	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.02e-05	0.000174	CbGpPWpGaD
Indapamide—Paraesthesia—Doxorubicin—hematologic cancer	1.02e-05	5.07e-05	CcSEcCtD
Indapamide—CA12—Metabolism—CREBBP—hematologic cancer	1.02e-05	0.000174	CbGpPWpGaD
Indapamide—Dyspnoea—Doxorubicin—hematologic cancer	1.01e-05	5.03e-05	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—hematologic cancer	1.01e-05	5.03e-05	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—hematologic cancer	1.01e-05	5.02e-05	CcSEcCtD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1e-05	0.000172	CbGpPWpGaD
Indapamide—Gastrointestinal pain—Epirubicin—hematologic cancer	1e-05	4.99e-05	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—hematologic cancer	9.98e-06	4.97e-05	CcSEcCtD
Indapamide—CA2—Metabolism—MTHFR—hematologic cancer	9.97e-06	0.000171	CbGpPWpGaD
Indapamide—Vomiting—Prednisone—hematologic cancer	9.96e-06	4.96e-05	CcSEcCtD
Indapamide—Rash—Prednisone—hematologic cancer	9.88e-06	4.92e-05	CcSEcCtD
Indapamide—Dermatitis—Prednisone—hematologic cancer	9.87e-06	4.92e-05	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—hematologic cancer	9.86e-06	4.91e-05	CcSEcCtD
Indapamide—CA7—Metabolism—PIK3R1—hematologic cancer	9.82e-06	0.000168	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3R1—hematologic cancer	9.82e-06	0.000168	CbGpPWpGaD
Indapamide—Headache—Prednisone—hematologic cancer	9.81e-06	4.89e-05	CcSEcCtD
Indapamide—CA9—Metabolism—ABCB1—hematologic cancer	9.8e-06	0.000168	CbGpPWpGaD
Indapamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.79e-06	4.87e-05	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—hematologic cancer	9.77e-06	4.87e-05	CcSEcCtD
Indapamide—Urticaria—Epirubicin—hematologic cancer	9.73e-06	4.85e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—PIK3CB—hematologic cancer	9.71e-06	0.000166	CbGpPWpGaD
Indapamide—Constipation—Doxorubicin—hematologic cancer	9.7e-06	4.83e-05	CcSEcCtD
Indapamide—Pain—Doxorubicin—hematologic cancer	9.7e-06	4.83e-05	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—hematologic cancer	9.69e-06	4.82e-05	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—hematologic cancer	9.69e-06	4.82e-05	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—hematologic cancer	9.65e-06	4.8e-05	CcSEcCtD
Indapamide—CA12—Metabolism—PIK3CD—hematologic cancer	9.63e-06	0.000165	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTM1—hematologic cancer	9.51e-06	0.000163	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOR1—hematologic cancer	9.51e-06	0.000163	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALB—hematologic cancer	9.51e-06	0.000163	CbGpPWpGaD
Indapamide—Asthenia—Methotrexate—hematologic cancer	9.39e-06	4.68e-05	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	9.36e-06	0.00016	CbGpPWpGaD
Indapamide—Feeling abnormal—Doxorubicin—hematologic cancer	9.34e-06	4.65e-05	CcSEcCtD
Indapamide—Nausea—Prednisone—hematologic cancer	9.31e-06	4.63e-05	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.27e-06	4.62e-05	CcSEcCtD
Indapamide—Pruritus—Methotrexate—hematologic cancer	9.26e-06	4.61e-05	CcSEcCtD
Indapamide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	9.23e-06	0.000158	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3R1—hematologic cancer	9.1e-06	0.000156	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CB—hematologic cancer	9.06e-06	0.000155	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CB—hematologic cancer	9.06e-06	0.000155	CbGpPWpGaD
Indapamide—Hypersensitivity—Epirubicin—hematologic cancer	9.03e-06	4.5e-05	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—hematologic cancer	9.01e-06	4.49e-05	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—hematologic cancer	8.96e-06	4.46e-05	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—hematologic cancer	8.96e-06	4.46e-05	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—hematologic cancer	8.96e-06	4.46e-05	CcSEcCtD
Indapamide—Asthenia—Epirubicin—hematologic cancer	8.79e-06	4.38e-05	CcSEcCtD
Indapamide—CA4—Metabolism—PIK3CG—hematologic cancer	8.74e-06	0.00015	CbGpPWpGaD
Indapamide—Pruritus—Epirubicin—hematologic cancer	8.67e-06	4.32e-05	CcSEcCtD
Indapamide—Dizziness—Methotrexate—hematologic cancer	8.66e-06	4.31e-05	CcSEcCtD
Indapamide—CA9—Metabolism—MTHFR—hematologic cancer	8.4e-06	0.000144	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CB—hematologic cancer	8.4e-06	0.000144	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTEN—hematologic cancer	8.39e-06	0.000144	CbGpPWpGaD
Indapamide—Diarrhoea—Epirubicin—hematologic cancer	8.38e-06	4.18e-05	CcSEcCtD
Indapamide—CA2—Metabolism—PIK3CG—hematologic cancer	8.38e-06	0.000143	CbGpPWpGaD
Indapamide—Hypersensitivity—Doxorubicin—hematologic cancer	8.35e-06	4.16e-05	CcSEcCtD
Indapamide—Vomiting—Methotrexate—hematologic cancer	8.33e-06	4.15e-05	CcSEcCtD
Indapamide—Rash—Methotrexate—hematologic cancer	8.26e-06	4.11e-05	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—hematologic cancer	8.25e-06	4.11e-05	CcSEcCtD
Indapamide—Headache—Methotrexate—hematologic cancer	8.2e-06	4.09e-05	CcSEcCtD
Indapamide—Asthenia—Doxorubicin—hematologic cancer	8.13e-06	4.05e-05	CcSEcCtD
Indapamide—Dizziness—Epirubicin—hematologic cancer	8.1e-06	4.04e-05	CcSEcCtD
Indapamide—CA4—Metabolism—CREBBP—hematologic cancer	8.1e-06	0.000139	CbGpPWpGaD
Indapamide—Pruritus—Doxorubicin—hematologic cancer	8.02e-06	3.99e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—EP300—hematologic cancer	8e-06	0.000137	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTEN—hematologic cancer	7.83e-06	0.000134	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTEN—hematologic cancer	7.83e-06	0.000134	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GMPS—hematologic cancer	7.81e-06	0.000134	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PHYH—hematologic cancer	7.81e-06	0.000134	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FTCD—hematologic cancer	7.81e-06	0.000134	CbGpPWpGaD
Indapamide—Vomiting—Epirubicin—hematologic cancer	7.79e-06	3.88e-05	CcSEcCtD
Indapamide—Nausea—Methotrexate—hematologic cancer	7.78e-06	3.87e-05	CcSEcCtD
Indapamide—CA2—Metabolism—CREBBP—hematologic cancer	7.77e-06	0.000133	CbGpPWpGaD
Indapamide—Diarrhoea—Doxorubicin—hematologic cancer	7.76e-06	3.86e-05	CcSEcCtD
Indapamide—Rash—Epirubicin—hematologic cancer	7.73e-06	3.85e-05	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—hematologic cancer	7.72e-06	3.84e-05	CcSEcCtD
Indapamide—CA4—Metabolism—PIK3CD—hematologic cancer	7.68e-06	0.000132	CbGpPWpGaD
Indapamide—Headache—Epirubicin—hematologic cancer	7.68e-06	3.82e-05	CcSEcCtD
Indapamide—CA4—Metabolism—ALB—hematologic cancer	7.58e-06	0.00013	CbGpPWpGaD
Indapamide—Dizziness—Doxorubicin—hematologic cancer	7.5e-06	3.73e-05	CcSEcCtD
Indapamide—CA7—Metabolism—EP300—hematologic cancer	7.47e-06	0.000128	CbGpPWpGaD
Indapamide—CA5B—Metabolism—EP300—hematologic cancer	7.47e-06	0.000128	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CD—hematologic cancer	7.37e-06	0.000126	CbGpPWpGaD
Indapamide—Nausea—Epirubicin—hematologic cancer	7.28e-06	3.62e-05	CcSEcCtD
Indapamide—CA2—Metabolism—ALB—hematologic cancer	7.27e-06	0.000124	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTEN—hematologic cancer	7.26e-06	0.000124	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3R1—hematologic cancer	7.25e-06	0.000124	CbGpPWpGaD
Indapamide—Vomiting—Doxorubicin—hematologic cancer	7.21e-06	3.59e-05	CcSEcCtD
Indapamide—Rash—Doxorubicin—hematologic cancer	7.15e-06	3.56e-05	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—hematologic cancer	7.14e-06	3.56e-05	CcSEcCtD
Indapamide—CYP3A4—Metabolism—SMPD3—hematologic cancer	7.14e-06	0.000122	CbGpPWpGaD
Indapamide—Headache—Doxorubicin—hematologic cancer	7.1e-06	3.54e-05	CcSEcCtD
Indapamide—CA9—Metabolism—PIK3CG—hematologic cancer	7.06e-06	0.000121	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3R1—hematologic cancer	6.96e-06	0.000119	CbGpPWpGaD
Indapamide—CA12—Metabolism—EP300—hematologic cancer	6.92e-06	0.000118	CbGpPWpGaD
Indapamide—Nausea—Doxorubicin—hematologic cancer	6.73e-06	3.35e-05	CcSEcCtD
Indapamide—CA4—Metabolism—PIK3CB—hematologic cancer	6.7e-06	0.000115	CbGpPWpGaD
Indapamide—CA9—Metabolism—CREBBP—hematologic cancer	6.55e-06	0.000112	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CB—hematologic cancer	6.42e-06	0.00011	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ASNS—hematologic cancer	6.24e-06	0.000107	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	6.24e-06	0.000107	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—DCK—hematologic cancer	6.24e-06	0.000107	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CD—hematologic cancer	6.21e-06	0.000106	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALB—hematologic cancer	6.13e-06	0.000105	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—hematologic cancer	5.92e-06	0.000101	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HDC—hematologic cancer	5.92e-06	0.000101	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3R1—hematologic cancer	5.86e-06	0.0001	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTEN—hematologic cancer	5.79e-06	9.91e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTEN—hematologic cancer	5.55e-06	9.5e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—hematologic cancer	5.53e-06	9.46e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—hematologic cancer	5.53e-06	9.46e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—EP300—hematologic cancer	5.52e-06	9.45e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CDA—hematologic cancer	5.41e-06	9.26e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CB—hematologic cancer	5.41e-06	9.26e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—EP300—hematologic cancer	5.29e-06	9.06e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PC—hematologic cancer	5.21e-06	8.92e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—hematologic cancer	5.12e-06	8.76e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.03e-06	8.61e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GBA—hematologic cancer	5.03e-06	8.61e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—hematologic cancer	4.84e-06	8.28e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTEN—hematologic cancer	4.68e-06	8.01e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTAP—hematologic cancer	4.6e-06	7.88e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—hematologic cancer	4.51e-06	7.73e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—hematologic cancer	4.51e-06	7.73e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—EP300—hematologic cancer	4.46e-06	7.63e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—hematologic cancer	4.18e-06	7.16e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FHL2—hematologic cancer	4.1e-06	7.02e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—hematologic cancer	4.08e-06	6.99e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AGRN—hematologic cancer	4.02e-06	6.89e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—hematologic cancer	3.91e-06	6.7e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HMMR—hematologic cancer	3.81e-06	6.53e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—IDH2—hematologic cancer	3.81e-06	6.53e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.58e-06	6.14e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA9—hematologic cancer	3.49e-06	5.97e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ACP5—hematologic cancer	3.49e-06	5.97e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.44e-06	5.89e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—hematologic cancer	3.33e-06	5.71e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—hematologic cancer	3.3e-06	5.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—IDH1—hematologic cancer	3.28e-06	5.61e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.24e-06	5.55e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TXN—hematologic cancer	3.24e-06	5.55e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.24e-06	5.55e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—hematologic cancer	3.2e-06	5.47e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.17e-06	5.43e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.05e-06	5.22e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.96e-06	5.08e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.96e-06	5.08e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.89e-06	4.95e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NUP98—hematologic cancer	2.8e-06	4.79e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.72e-06	4.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.72e-06	4.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NUP214—hematologic cancer	2.7e-06	4.62e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—hematologic cancer	2.69e-06	4.61e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTR—hematologic cancer	2.64e-06	4.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.64e-06	4.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ENO2—hematologic cancer	2.59e-06	4.44e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.51e-06	4.3e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SDC1—hematologic cancer	2.46e-06	4.21e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NQO1—hematologic cancer	2.09e-06	3.58e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CD44—hematologic cancer	2.09e-06	3.58e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYCS—hematologic cancer	1.98e-06	3.38e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.96e-06	3.36e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.74e-06	2.98e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.65e-06	2.82e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.6e-06	2.74e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.6e-06	2.74e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.41e-06	2.42e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.19e-06	2.04e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.1e-06	1.89e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.05e-06	1.79e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALB—hematologic cancer	1.03e-06	1.77e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.87e-07	1.69e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.11e-07	1.56e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTEN—hematologic cancer	7.87e-07	1.35e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—EP300—hematologic cancer	7.51e-07	1.29e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.55e-07	9.51e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—hematologic cancer	4.54e-07	7.77e-06	CbGpPWpGaD
